Identifiable assets
Breakdown
| Segment | Q4 '22 | Q4 '23 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 |
|---|---|---|---|---|---|---|---|
| Biotechnology | $37.5B | $37.4B | $34.6B | $36.1B | $37.6B | $37.3B | $37.3B |
| Life Sciences | — | — | — | — | — | — | $23.1B |
| Diagnostics | — | — | — | — | — | — | $14.7B |
| Total | $84.4B | $84.5B | $77.5B | $79.1B | $81.6B | $79.9B | $83.5B |